TCT 257: FFR-Guided PCI Optimization Directed by High-Definition IVUS Versus Standard of Care: 2-year Results from the FFR REACT Trial
We Recommend
Disclosures
Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:
- Grant Support/Research Contract (Institutional) - AstraZenca; Abbott Vascular; Boston Scientific Corporation; ACIST; Medtronic; Pie Medical; ReCor medical
- Consultant Fee/Honoraria/Speaker's Bureau (Personal) - ACIST; Boston Scientific Corporation; Siemens Healthineers; Pie Medical; Medtronic; PulseCath BV